ABOUT US |
Able Cerebral, LLC (ACL) is an innovative technology company with patents granted. We conquered technical challenges and physiological misconceptions of brain energy molecules (mainly glucose, the safest essential biological elements after air and water) to solve the unsolvable health problems like Alzheimer’s, and obesity.
ACL is currently focused on the two R&D areas (seeking partnership or out-licensing):
Able Cerebral is the pioneer in connecting the dots between nocturnal hypoglycemia with cognitive and memory deterioration. Using our timed release of brain energy molecules as the foundation for brain energy supply, we are building an internal team and partnering with other technology enterprises to conquer the unmet challenge facing AD and MCI communities. To reinforce our commitment to combating the global obesity crisis, ACL initiated a strategic campaign in 2026 seeking investment and biopharmaceutical partnerships. This initiative aims to license our patented enhancer technology, which is designed to optimize the development and delivery of oral GLP-1 dosage forms. Our flagship product BrainGlucose caplet is made with a combination of several controlled release mechanisms, which has been designed and tested for diabetes patients who are suffering from nocturnal hypoglycemia. As CDC reports, nearly three hundred thousand emergency cares due to hypoglycemia incidents annually in United States alone. Even worse, there are hundreds of millions diabetics worldwide who unaware of their nocturnal hypoglycemia, which is the silent killer of their memories. We have filed several patent applications with the USPTO and corresponding international institutions for the current and future products in the pipeline. Recently, we have been granted US, Canada, and China patents for timed release of brain energy supply, and for memory recovery system.
03.
AddMem is a non-invasive medical device for memory recovery and consolidation for mid to late stage memory loss patients. It is under development. |